SQUAWK/NEWS
Account
Theme
Account
Menu
Live News NEWS FLASH L impact

Teva Pharmaceuticals Price Target Announced at $50.00/Share by Oppenheimer

Ratings actions from Benzinga: GMT) Teva Pharmaceuticals Initiated at Outperform by OppenheimerRatings actions from Benzinga

TEVA

Related stories